{
  "@context": {
    "bioagents": "https://bio.agents/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.agents/NMTF",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalAgent/0.6-DRAFT",
      "sc:additionalType": "Library",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_2640"
        },
        {
          "@id": "edam:topic_0602"
        },
        {
          "@id": "edam:topic_0625"
        }
      ],
      "sc:citation": {
        "@id": "https://doi.org/10.1101/739110"
      },
      "sc:description": "Bayesian semi-nonnegative matrix tri-factorization to identify pathways associated with cancer phenotypes | Bayesian Semi-Nonnegative Matrix Tri-Factorization | BSNMTF is a semi-nonnegative matrix tri-factorization method in the framework of Bayesian learning to identify pathways associated with cancer phenotypes (e.g., cancer sub-types or treatment outcome) from a real-valued input matrix (e.g., copy number alterations or normalized log transformed gene expression data)",
      "sc:featureList": [
        {
          "@id": "edam:operation_3891"
        },
        {
          "@id": "edam:operation_3501"
        }
      ],
      "sc:name": "NMTF",
      "sc:url": "https://github.com/parks-cs-ccf/BayesianSNMTF"
    },
    {
      "@id": "https://doi.org/10.1101/739110",
      "@type": "sc:CreativeWork"
    }
  ]
}